Observational Study
Copyright ©The Author(s) 2025.
World J Diabetes. Feb 15, 2025; 16(2): 98085
Published online Feb 15, 2025. doi: 10.4239/wjd.v16.i2.98085
Table 1 Demographic and clinical characteristics of study population
VariableTotal
Obesity
Overweight
Normal weight
n = 1967
Diabetes, n = 162
Non-diabetes, n = 370
Diabetes, n = 184
Non-diabetes, n = 683
Diabetes, n = 81
Non-diabetes, n = 487
Age (years)59.4 ± 6.759.5 ± 6.158.8 ± 6.259.8 ± 6.959.2 ± 6.861.1 ± 6.859.8 ± 7.20
Men (%)49.135.837.353.850.754.357.7
Annual household income (%)
        < ¥5000060.353.757.048.960.865.467.8
        ¥50000-9900030.132.133.636.930.022.225.9
        ≥ ¥1000009.514.29.514.29.212.46.4
Education (%)
        Elementary school or lower33.639.533.229.329.945.736.8
        Middle school60.051.960.959.762.454.359.8
        College or higher6.48.75.710.87.703.5
BMI (kg/m2)26.09 ± 3.4730.53 ± 2.2530.40 ± 2.2225.97 ± 1.1526.01 ± 1.1422.35 ± 1.2122.12 ± 1.34
WC (cm)88.0 ± 9.699.0 ± 6.997.6 ± 6.9a89.8 ± 6.187.5 ± 5.9b80.5 ± 5.580.0 ± 5.7
HC (cm)98.4 ± 6.9104.9 ± 5.9105.2 ± 6.297.3 ± 4.798.3 ± 4.7b92.3 ± 5.0492.7 ± 4.7
WHR0.89 ± 0.070.94 ± 0.060.93 ± 0.06a0.92 ± 0.060.89 ± 0.06b0.87 ± 0.060.84 ± 0.06b
ALT (U/L)22.5 ± 12.228.8 ± 20.623.9 ± 10.8b24.1 ± 16.722.2 ± 11.0a19.3 ± 8.919.6 ± 7.8
AST (U/L)23.3 ± 8.928.5 ± 14.423.5 ± 8.723.2 ± 13.823.0 ± 7.2a21.1 ± 8.023.2 ± 6.0b
Cr (μmol/L)63.4 ± 33.661.6 ± 17.362.0 ± 14.268.4 ± 56.962.1 ± 14.576.6 ± 103.762.8 ± 31.5
FPG (mmol/L)6.38 ± 1.818.59 ± 2.285.80 ± 0.54b8.44 ± 2.235.76 ± 0.58b9.54 ± 3.815.64 ± 0.55b
FINS (uIU/mL)9.25 ± 6.8815.55 ± 10.0912.02 ± 6.19b11.19 ± 10.168.57 ± 4.11b7.42 ± 11.535.60 ± 3.00
HbA1c (%)6.03 ± 1.047.31 ± 1.365.80 ± 0.477.12 ± 1.345.69 ± 0.40b7.30 ± 1.805.62 ± 0.70b
HOMA-IR2.74 ± 2.696.07 ± 4.633.14 ± 1.82b4.22 ± 4.102.22 ± 1.16b3.04 ± 4.941.42 ± 1.84b
SBP (mmHg)133 ± 18137 ± 17136 ± 18137 ± 19132 ± 16136 ± 21130 ± 18
DBP (mmHg)79 ± 1181 ± 1182 ± 1279 ± 1079 ± 1075 ± 1176 ± 11a
Cholesterol (mmol/L)5.09 ± 1.415.27 ± 1.315.15 ± 1.095.15 ± 1.125.03 ± 0.945.14 ± 1.215.04 ± 0.92
Triglyceride (mmol/L)1.59 ± 1.412.26 ± 1.491.87 ± 1.51b2.00 ± 2.011.51 ± 1.13b1.41 ± 1.241.13 ± 1.21a
LDL-C (mmol/L)2.98 ± 0.843.06 ± 0.913.07 ± 0.912.97 ± 0.932.99 ± 0.782.89 ± 0.932.91 ± 0.77
HDL-C (mmol/L)1.18 ± 0.311.06 ± 0.181.09 ± 0.241.11 ± 0.291.17 ± 0.27b1.30 ± 0.441.33 ± 0.36
vBMD103.0 ± 30.8105.9 ± 33.2102.1 ± 29.4104.0 ± 32.9103.9 ± 30.6101.6 ± 30.4100.8 ± 30.9
Table 2 Saturation effect analysis of body mass index and volumetric bone mineral density
        Diabetes
Non-diabetes
Total
β (95%CI)
P value
β (95%CI)
P value
β (95%CI)
P value
vBMD
    Model 1
        One line effect0.54 (-0.20, 1.29)0.1550.40 (0.01, 0.78)0.0430.43 (0.09, 0.77)0.014
    Model 2
        BMI turning point (K), kg/m229.2421.4821.42
        < K, effect 10.28 (-0.81, 1.38)0.6123.84 (0.41, 7.26)0.0283.70 (0.33, 7.08)0.032
        > K, effect 21.12 (-0.83, 3.06)0.2610.21 (-0.22, 0.64)0.3390.28 (-0.09, 0.66)0.139
        Effect 2 - 10.83 (-1.77, 3.43)0.532-3.63 (-7.22, -0.04)0.048-3.42 (-6.93, 0.09)0.056
        LRT test0.5290.0470.056
Men
    Model 1
        One line effect0.33 (-0.86, 1.52)0.5890.53 (-0.08, 1.15)0.0430.49 (-0.06, 1.04)0.080
    Model 2
        BMI turning point (K), kg/m226.4522.3321.65
        < K, effect 11.07 (-1.26, 3.39)0.3703.51 (0.56, 6.46)0.0203.93 (0.14, 7.72)0.042
        > K, effect 2-0.33 (-2.48, 1.82)0.7630.05 (-0.73, 0.82)0.9070.19 (-0.45, 0.83)0.567
        Effect 2 - 1-1.40 (-5.18, 2.38)0.470-3.46 (-6.82, -0.11)0.043-3.74 (-7.82, 0.34)0.072
        LRT test0.4650.0430.072
Women
    Model 1
        One line effect0.7 (-0.2, 1.7)0.1330.4 (-0.1, 0.8)0.1430.49 (-0.06, 1.04)0.080
    Model 2
        BMI turning point (K), kg/m227.328.729
        < K, effect 1-0.2 (-2.4, 2.0)0.844-0.1 (-0.8, 0.6)0.760-0.1 (-0.7, 0.6)0.879
        > K, effect 21.4 (-0.3, 3.1)0.1081.3 (0.1, 2.5)0.0351.4 (0.4, 2.5)0.009
        Effect 2 - 11.6 (-1.8, 5.0)0.3471.4 (-0.2, 3.0)0.0961.5 (0, 3.0)0.049
        LRT test0.3420.0950.049